172 related articles for article (PubMed ID: 35335257)
21. Relationship between immobilised artificial membrane chromatographic retention and the brain penetration of structurally diverse drugs.
Salminen T; Pulli A; Taskinen J
J Pharm Biomed Anal; 1997 Jan; 15(4):469-77. PubMed ID: 8953490
[TBL] [Abstract][Full Text] [Related]
22. Immobilized-artificial-membrane chromatography: measurements of membrane partition coefficient and predicting drug membrane permeability.
Ong S; Liu H; Pidgeon C
J Chromatogr A; 1996 Mar; 728(1-2):113-28. PubMed ID: 8673230
[TBL] [Abstract][Full Text] [Related]
23. Relationship between immobilized artificial membrane chromatographic retention and human oral absorption of structurally diverse drugs.
Kotecha J; Shah S; Rathod I; Subbaiah G
Int J Pharm; 2007 Mar; 333(1-2):127-35. PubMed ID: 17095172
[TBL] [Abstract][Full Text] [Related]
24. Prediction of oral absorption in humans by experimental immobilized artificial membrane chromatography indices and physicochemical descriptors.
Kotecha J; Shah S; Rathod I; Subbaiah G
Int J Pharm; 2008 Aug; 360(1-2):96-106. PubMed ID: 18524510
[TBL] [Abstract][Full Text] [Related]
25. Prediction of immobilized artificial membrane-liquid chromatography retention of some drugs from their molecular structure descriptors and LFER parameters.
Fatemi MH; Shamseddin H
J Sep Sci; 2009 Oct; 32(20):3395-402. PubMed ID: 19750506
[TBL] [Abstract][Full Text] [Related]
26. Quantitative structure-retention relationship studies using immobilized artificial membrane chromatography I: amended linear solvation energy relationships with the introduction of a molecular electronic factor.
Li J; Sun J; Cui S; He Z
J Chromatogr A; 2006 Nov; 1132(1-2):174-82. PubMed ID: 16919656
[TBL] [Abstract][Full Text] [Related]
27. Retention behavior of flavonoids on immobilized artificial membrane chromatography and correlation with cell-based permeability.
Tsopelas F; Tsagkrasouli M; Poursanidis P; Pitsaki M; Vasios G; Danias P; Panderi I; Tsantili-Kakoulidou A; Giaginis C
Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 29044623
[TBL] [Abstract][Full Text] [Related]
28. Database of published retention factors for immobilized artificial membrane HPLC and an assessment of the effect of experimental variability.
Ledbetter MR; Gutsell S; Hodges G; Madden JC; O'Connor S; Cronin MT
Environ Toxicol Chem; 2011 Dec; 30(12):2701-8. PubMed ID: 21919042
[TBL] [Abstract][Full Text] [Related]
29. Quantitative structure-retention relationship studies with immobilized artificial membrane chromatography II: partial least squares regression.
Li J; Sun J; He Z
J Chromatogr A; 2007 Jan; 1140(1-2):174-9. PubMed ID: 17161410
[TBL] [Abstract][Full Text] [Related]
30. Indexes of polar interactions between ionizable drugs and membrane phospholipids measured by IAM-HPLC: their relationships with data of Blood-Brain Barrier passage.
Grumetto L; Russo G; Barbato F
Eur J Pharm Sci; 2014 Dec; 65():139-46. PubMed ID: 25262853
[TBL] [Abstract][Full Text] [Related]
31. Permeability Data of Organosulfur Garlic Compounds Estimated by Immobilized Artificial Membrane Chromatography: Correlation Across Several Biological Barriers.
Ramirez DA; Federici MF; Altamirano JC; Camargo AB; Luco JM
Front Chem; 2021; 9():690707. PubMed ID: 34616711
[TBL] [Abstract][Full Text] [Related]
32. Quantitative structure-retention relationships of flavonoids unraveled by immobilized artificial membrane chromatography.
Santoro AL; Carrilho E; Lanças FM; Montanari CA
Eur J Pharm Sci; 2016 Jun; 88():147-57. PubMed ID: 26916828
[TBL] [Abstract][Full Text] [Related]
33. Modeling the Blood-Brain Barrier Permeability of Potential Heterocyclic Drugs via Biomimetic IAM Chromatography Technique Combined with QSAR Methodology.
Janicka M; Sztanke M; Sztanke K
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257200
[TBL] [Abstract][Full Text] [Related]
34. Keratin immobilized on silica as a new stationary phase for chromatographic modelling of skin permeation.
Turowski M; Kaliszan R
J Pharm Biomed Anal; 1997 Jun; 15(9-10):1325-33. PubMed ID: 9226560
[TBL] [Abstract][Full Text] [Related]
35. Comparison between immobilized artificial membrane (IAM) HPLC data and lipophilicity in n-octanol for quinolone antibacterial agents.
Barbato F; Cirocco V; Grumetto L; Immacolata La Rotonda M
Eur J Pharm Sci; 2007 Aug; 31(5):288-97. PubMed ID: 17540545
[TBL] [Abstract][Full Text] [Related]
36. Chromatographic Data in Statistical Analysis of BBB Permeability Indices.
Wanat K; Brzezińska E
Membranes (Basel); 2023 Jun; 13(7):. PubMed ID: 37504989
[TBL] [Abstract][Full Text] [Related]
37. Linear free energy relationship analysis of permeability across polydimethylsiloxane (PDMS) membranes and comparison with human skin permeation in vitro.
Liu X; Zhang K; Abraham MH
Eur J Pharm Sci; 2018 Oct; 123():524-530. PubMed ID: 30107227
[TBL] [Abstract][Full Text] [Related]
38. Deactivated hydrocarbonaceous silica and immobilized artificial membrane stationary phases in high-performance liquid chromatographic determination of hydrophobicities of organic bases: relationship to log P and CLOGP.
Kaliszan R; Kaliszan A; Wainer IW
J Pharm Biomed Anal; 1993 Jun; 11(6):505-11. PubMed ID: 8399522
[TBL] [Abstract][Full Text] [Related]
39. The potential of immobilized artificial membrane chromatography to predict human oral absorption.
Tsopelas F; Vallianatou T; Tsantili-Kakoulidou A
Eur J Pharm Sci; 2016 Jan; 81():82-93. PubMed ID: 26485055
[TBL] [Abstract][Full Text] [Related]
40. Learning how to use IAM chromatography for predicting permeability.
Ermondi G; Vallaro M; Caron G
Eur J Pharm Sci; 2018 Mar; 114():385-390. PubMed ID: 29305983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
